Class Action Feeding Frenzy Could Chill On Legislation, Judicial Shift
This article was originally published in The Rose Sheet
Executive Summary
Food and supplement class action complaints could be slowed by legislation in Congress and by judges potentially de-emphasizing reliance on FDA interpretation of statutes, say lawyers during FDLI conference discussion.
You may also be interested in...
Pharmavite Agrees To $1.9M Settlement In TripleFlex Class Action
Pharmavite will pay $1.9m and discontinue joint improvement claims for four Nature Made TripleFlex glucosamine products under terms of a class-action settlement in a six-year dispute over the truthfulness of joint renewal and rejuvenation claims.
Supplement Space Exits: Bankruptcy Traffic Could Accelerate
Gaspari Nutrition, acquired by Allegro Nutrition, sought Chapter 11 protection after its debt load outstripped its revenue outlook. Natrol threw in the towel and filed after federal judges consolidated multiple class action claims accusing the firm of false advertising for its joint relief products.
Saw Palmetto denial
High court refuses petitioners who requested the court review FDA's denial of a health claim linking saw palmetto to benign prostatic hyperplasia, law firm Emord & Associates says Oct. 12. Julian Whitaker, et al., filed the writ of certiorari earlier this year (1"The Tan Sheet" Jan. 19, 2004, p. 16)...